NASDAQ · Drug Manufacturers - Specialty & Generic

UPC (UPC) Stock

$3.45 +1.77% NASDAQ: UPC Healthcare

Valuation

MetricValue
Price$3.45
Market Cap$2.18M
P/E Ratio0.00
P/B Ratio0.03
P/S Ratio0.09
EPS (TTM)$-1055.75
52-Week High$14.25
52-Week Low$2.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-7.14%
ROA-5.80%
ROCE-5.36%
Gross Margin-16.67%
Operating Margin-16.67%
Net Margin-20.56%
Debt/Equity0.16
Current Ratio4.15

Annual Financials (USD)

Metric20212022202320242025
Revenue$48.0M$40.0M$32.0M$23.0M$18.0M
Operating Profit$14.0M$-7.0M$-4.0M$-8.0M$-3.0M
Net Profit$11.0M$-9.0M$-6.0M$-9.0M$-4.0M
EPS$2147.18$-1475.02$-1040.53$-1436.12$-1055.75
Op Margin28.3%-17.5%-10.9%-34.8%-16.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$70.0M$60.0M$53.0M$68.0M$69.0M
Total Liabilities$11.0M$13.0M$14.0M$22.0M$13.0M
Cash$8.0M$6.0M$5.0M$29.0M$34.0M
Borrowings$4.0M$4.0M$5.0M$8.0M$9.0M

Latest News

Top Premarket Decliners MT Newswires · Jun 30, 2026 Top Midday Gainers MT Newswires · Jun 29, 2026 Top Premarket Gainers MT Newswires · Jun 29, 2026 UPC Stock Surges 288% After Hours — What’s Driving The Rally? Stocktwits · Jun 26, 2026 Universe Pharmaceuticals to Acquire Best Praise International MT Newswires · Jun 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-1.0M$1.0M$-10.0M$-5.0M
Investing Cash Flow$-41.0M$-4.0M$0$-1.0M$-1.0M
Financing Cash Flow$-3.0M$0$0$0$0
Net Cash Flow$-2.0M$-2.0M$0$24.0M$4.0M
Free Cash Flow$-16.0M$-1.0M$1.0M$-10.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-349.71%
Quick Ratio3.90
Interest Coverage—
Return 1Y31.72%
Return 3Y-99.63%
Return 5Y-99.95%

Ownership

Insiders Held11.38%
Institutions Held4.45%
Institutions Float Held5.02%
Institutional HolderSharesReport Date
UBS Group AG9462025-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BCTXZBriaCell Therapeutics Corp. Warrant $0.10 +8.47% -0.30 $188186 0.00%
BJDX $1.10 +6.80% -0.32 $498895 0.00%
ELAB $0.92 +2.21% 0.00 $1.78M 0.00%
MLECMoolec Science S.A. $7.37 +2.43% -0.03 $5.35M 0.00%
NCEL $3.60 -4.13% -0.13 $1.62M 0.00%

About UPC

UPC is led by CEO Gang Lai, employs 225 people, headquartered in CN, publicly traded since 2021.

UPC stock trades at $3.45 with a market capitalization of $2.18M. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.03, price-to-sales of 0.09. Over the past 52 weeks the stock has ranged between $2.00 and $14.25, and currently trades 75.8% below its 52-week high.

On profitability, UPC generates a return on equity (ROE) of -7.14%, return on capital employed of -5.36%, an operating margin of -16.67%, a net profit margin of -20.56%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides